[CAS NO. 1002-84-2] Pentadecanoic acid
PRODUCTS SPECIFICATIONS [1002-84-2]
DESCRIPTION [1002-84-2]
Overview
| MDL | MFCD00002745 |
|---|---|
| Molecular Weight | 242.40 |
| Molecular Formula | C15H30O2 |
| SMILES | O=C(CCCCCCCCCCCCCC)O |
Summary
Pentadecylic acid is a saturated fatty acid with a 15-carbon backbone.
IC50 & Target
|
Human Endogenous Metabolite |
Clinical Trial
| NCT Number | Sponsor | Condition | Start Date | Phase |
|---|---|---|---|---|
| NCT00572975 | Children´s Hospital of Philadelphia|Solvay Pharmaceuticals |
Cystic Fibrosis|Pancreatic Insufficiency
|
August 2006 | Phase 4 |
Appearance
Solid
Shipping
Room temperature in continental US; may vary elsewhere.
Storage
| Powder | -20°C | 3 years |
|---|---|---|
| 4°C | 2 years | |
| In solvent | -80°C | 6 months |
| -20°C | 1 month |
Solvent & Solubility
DMSO : 62.5 mg/mL ( 257.84 mM ; Need ultrasonic)
Stock Solutions
| Concentration Solvent Mass | 1 mg | 5 mg | 10 mg |
|---|
| 1 mM | 4.1254 mL | 20.6271 mL | 41.2541 mL |
| 5 mM | 0.8251 mL | 4.1254 mL | 8.2508 mL |
| 10 mM | 0.4125 mL | 2.0627 mL | 4.1254 mL |
-
1.
-
2.
Add each solvent one by one: 10% DMSO >> 90% corn oil
Solubility: ≥ 2.08 mg/mL (8.58 mM); Clear solution
Synonyms